Cascadian Therapeutics Inc

FRA:3O61 (USA)  
(Delisted) € 8.01 (0%) Mar 14
At Loss
Market Cap:
€ 447.29M ($ 485.31M)
Enterprise V:
€ 447.29M ($ 485.31M)
Volume:
-
Avg Vol (2M):
-

Cascadian Therapeutics Inc Operating Data

Cascadian Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Cascadian Therapeutics Inc (FRA:3O61) Operating Data Charts